NEOONSITE

Welcome to the Brand page for “NEOONSITE”, which is offered here for In the statement, class 5 has been corrected per the restriction dated 8/30/18, and per the fnote dated 10/3/18.;pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; * diagnostic preparations for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases * [ diagnostic preparations for medical purposes ] ; chemical preparations for analyses in laboratories, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, for the detection [, ] * and * analysis [ and treatment ] of cancer; cultures of microorganisms for medical and veterinary use *, for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases *;neo on-site;neo on site; in the statement, international class 5 is corrected per the restriction and the fnote dated 1/29/2019.;medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases;scientific and technological services, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software;.

Its status is currently believed to be active. Its class is unavailable. “NEOONSITE” is believed to be currently owned by “SIEMENS HEALTHCARE GMBH”.


Owner:
SIEMENS HEALTHCARE GMBH
Owner Details
Description:
In the Statement, class 5 has been corrected per the Restriction dated 8/30/18, and per the Fnote dated 10/3/18.;Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; * diagnostic preparations for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases * [ diagnostic preparations for medical purposes ] ; chemical preparations for analyses in laboratories, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, for the detection [, ] * and * analysis [ and treatment ] of cancer; cultures of microorganisms for medical and veterinary use *, for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases *;NEO ON-SITE;NEO ON SITE; In the statement, International class 5 is corrected per the restriction and the fnote dated 1/29/2019.;Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases;Scientific and technological services, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software;
Categories: STATEMENT